Minor role played by type I tumour necrosis factor receptor in the control of Mycobacterium avium proliferation in infected mice

Immunology

Volumn 99, Issue 2, 2000, Pages 203-207

  Silva, R A ^b   Gomes, M S ^b   Appelberg, R ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 12; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE DISRUPTION; GENETIC ENGINEERING; HEPATITIS; HETEROZYGOTE; INFECTION CONTROL; LUNG INFECTION; MALE; MOUSE; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN;

ANIMALS; INTERLEUKIN-12; LIVER; LUNG; MICE; MICE, INBRED C57BL; MYCOBACTERIUM AVIUM; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; SPLEEN; TUBERCULOSIS;

EID: 0033981353     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00937.x     Document Type: Article

References (20)

1. 1. Inderlied C.B., Kemper C.A. & Bermudez L.E.M. (1993) The Mycobacterium avium complex. Clin Microbiol Rev 6, 266.
2. 2. Ottenhoff T.H.M., Kumararatne D. & Casanova J.-L. (1998) Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular infections. Immunol Today 19, 491.
3. 3. Appelberg R. (1996) Immune response to atypical mycobacteria. In: 67th Forum in Immunology 'Immunity to Intracellular Bacteria' (eds S.H.E. Kaufmann & G. Kaplan).Res Immunol 147, 560.
4. 4. Flórido M., Gonçalves A.S., Silva R.A., Ehlers S., Cooper A.M. & Appelberg R. (1999) Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis. Infect Immun 67, 3610.
5. 5. Appelberg R. & Orme I.M. (1993) Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages. Immunology 80, 352.
6. 6. Bermudez L.E.M. & Young L.S. (1988) Tumor necrosis factor, alone or in combination with IL-2, but not IFN-γ, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 140, 3006.
7. 7. Denis M. (1991) Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumor necrosis factor in resistance to atypical mycobacteria. Clin Exp Immunol 83, 466.
8. 8. Sarmento A.M. & Appelberg R. (1995) Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor-α production in infected mice and in vitro-cultured mouse macrophages. Infect Immun 63, 3759.
9. 9. Furney S.K., Skinner P.S., Roberts A.D., Appelberg R. & Orme I.M. (1992) Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce the secretion of tumor necrosis factor. Infect Immun 60, 4410.
10. 10. Gruss H.-J. & Dower S.K. (1995) Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 85, 3378.
11. 11. Flynn J.L., Goldstein M., Chan J. et al. (1995) Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2, 561.
12. 12. Silva R.A., Pais T.F. & Appelberg R. (1998) Evaluation of interleukin 12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections. J Immunol 161, 5578.
13. 13. Appelberg R., Castro A.G., Pedrosa J., Silva R.A., Orme I.M. & Minóprio P. (1994) The role of gamma interferon and tumor necrosis factor-alpha during the T cell independent and dependent phases of Mycobacterium avium infection. Infect Immun 62, 3962.
14. 14. Appelberg R., Sarmento A. & Castro A.G. (1995) Tumor necrosis factor alpha (TNFα) in the host resistance to mycobacteria of distinct virulence. Clin Exp Immunol 101, 308.
15. 15. Bean A.G.D., Roach D.R., Briscoe H. et al. (1999) Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 162, 3504.
16. 16. Ehlers S., Benini J., Kutsch S., Endres R., Rietschel E.T. & Pfeffer K. (1999) Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect Immun 67, 3571.
17. / mice: protection despite absence of ROI and susceptibility despite presence of RNI. Immunity 7, 419.
18. 18. Lucas R., Juillard P., Decoster E. et al. (1997) Crucial role of tumor necrosis (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol 27, 1719.
19. 19. Gomes M.S., Flórido M., Pais T.F. & Appelberg R. (1999) Improved clearance of Mycobacterium avium upon disruption of the iNOS gene. J Immunol 162, 6734.
20. phox / mouse model of chronic granulomatous disease has normal granuloma formation and cytokine responses to Mycobacterium avium and Schistosoma mansoni eggs. Infect Immun 67, 1659.